Carbon ion radiotherapy for stage I non-small cell lung cancer
Not Applicable
- Conditions
- clinical stage I non-small cell lung cancer
- Registration Number
- JPRN-UMIN000003797
- Lead Sponsor
- Gunma University Heavy Ion Medical Center
- Brief Summary
The median follow-up period was 56.3 months for all patients and 62.2 months for living patients. The actuarial 2-year, 3-year, and 5-year local control rates were 91.2%, 88.1%, and 88.1%, respectively. The actuarial 2-year, 3-year, and 5-year overall survival rates were 91.9%, 80.0%, and 74.9%, respectively. No patients with T1 disease experienced toxicities in grade 2 or worse severity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Not provided
Exclusion Criteria
1. past history of irradiation to the target 2. past history of chemotherapy within 4 weeks before treatment 3. life expectancy less than 6 months 4. Uncontrolled infection of lung 5. Active interstitial lung disease 6. Active double cancers 7. Other medical or psychological unsuitable reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method local control rate at 2 years
- Secondary Outcome Measures
Name Time Method